The CDC considers people with HIV to be at risk of severe mpox disease and recommends prioritization of those at risk for receipt of the JYNNEOS mpox vaccine. Vaccination is used to prevent mpox and as postexposure prophylaxis; it protects against disease when administered before exposure. If administered after exposure, the vaccine may prevent development or decrease the severity of mpox disease. Go to Guidelines Program Recommendations
Expedited partner therapy (EPT) is an essential, low-barrier health service for treating all patients with STIs and their sex partners. The New York State Department of Health AIDS Institute encourages care providers to make EPT as available as possible. This guidance for clinicians provides information about existing regulations that allow for EPT for sex partners of individuals diagnosed with gonorrhea, chlamydia, or trichomoniasis and answers questions regarding:
- How EPT is defined and whether it’s legal
- Who is eligible for EPT
- Preferred and alternative medication regimens for EPT
- How EPT is provided and paid for
- Key points for patient education
- Follow-up
Adopting a patient-centered sexual health framework when implementing Clinical Guidelines Program recommendations and guidance for clinical care of people with HIV and other STIs can improve patients’ overall health and well-being, reduce stigma, empower patients, and increase their uptake of sexual health–related resources. The patient-centered, HIV status–neutral approach to sexual health encouraged here promotes disease prevention and harm reduction and recognizes that there is much more to sexual health than disease prevention and treatment.
Please refer to CDC > Sexually Transmitted Infections Treatment Guidelines, 2021
Please refer to CDC > Sexually Transmitted Infections Treatment Guidelines, 2021